ABBV

AbbVie Inc. · Healthcare · Drug Manufacturers - General
$255.48
-2.67 (-1.03%)
Mkt Cap: 451.38B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield4.4%
Dividend YieldN/A
Market Cap451.38B
Volume3.22M
Recent News
AbbVie Seeks EU Nod for Subcutaneous Skyrizi in Crohn's Disease
zacks.com · 2026-08-28
Beverly Hills Private Wealth LLC Reduces Stake in AbbVie Inc. $ABBV
defenseworld.net · 2026-08-28
3 Dividend Stocks, 12 Paychecks a Year: How to Get Paid Every Month
247wallst.com · 2026-08-27
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
zacks.com · 2026-08-27
When Inflation Is Sticky, 5 Dividend Aristocrats Are the Stocks to Own Now and Forever
247wallst.com · 2026-08-27
AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
prnewswire.com · 2026-08-27

Unlock the Full Deep Scan

9 AI agents analyze ABBV across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →